Lung cancer has decreased mortality rates each year that can treat with radiotherapy. The radiotherapy module is own by 3D Slicer that is open-source software. The purpose is to determine the distribution of doses on the dose-volume histogram (DVH) and the percentage of the suitability of the 3D Slicer simulation results with the Treatment Planning System (TPS) at MRCCC Siloam Hospital. The data used were three Computed Tomographic images of lung cancer patients obtained from the MRCCC Siloam Hospital. The parameters analyzed included volume, the dose of the target volume, and organ at risk (OAR). Analytical studies were carried out by comparing the target volume with The International Commission on Radiation Unit (ICRU) Report 83 and comparing the OAR regarding dose tolerance. The dose distribution of all patients from the simulated 3D slicer for OAR met the tolerance limit reference recommendations. The Planning Target Volume (PTV) of all patients also matched the evaluation recommended by the ICRU Report 83. The percentage value of the suitability between the 3D Slicer and TPS results for all patients was above 95%. It shows that 3D Slicer can use as a recommendation software for initial radiotherapy planning studies.

No abstract

Treatment planning aimed to provide the maximum dose to target tumor and minimize doses received by healthy tissue. Dose-volume histograms contain essential information about the dose distribution that radiation oncologists use in considering a treatment planning. In breast cancer mastectomy, the thickness of the thorax wall has decreased because of surgery. Therefore it is necessary to analyze the dose received by healthy tissue around the tumor. This study analyzes the doses distribution in breast cancer mastectomy using SlicerRT and compares it with treatment planning from the hospital. The study used three data patients from MRCCC Siloam Hospitals Jakarta. The simulation results were analyzed based on the International Commission on Radiation Units and Measurements Report’s 83 for target tumor and tolerance limits of healthy tissue according to limitations from various references. Although the target tumor’s homogeneity does not qualify, the healthy tissue around the tumor is still within tolerance. It is not a problem in intensity-modulated radiation therapy if avoidance of healthy tissue is more important than homogeneity. For the comparison result, the percentage acceptance of SlicerRT simulation is quite good, above 90%.